|
|
||||||||
1 Laboratory for Physiology, Department of Pharmacology, University of Antwerp, Antwerp, Belgium
2 Cardiovascular Research, Department of Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston
| ABSTRACT |
|---|
|
|
|---|
heart; gene expression; microarray analysis; endothelium; cardiomyocyte
| INTRODUCTION |
|---|
|
|
|---|
Endothelial diversity is most striking where the endothelium has developed unique functional adaptations required for a specific organ function. The endothelium in the corneal microcirculation, for example, creates transendothelial ion fluxes that underlie the corneal fluid pump, which is essential to counterbalance fluid leak into the cornea through the corneal endothelium (3). Similarly, the endothelial layer of the blood-brain barrier forms a tight interface between blood and neuronal tissue, with active transport systems that create a milieu essential for the function of the underlying neuronal cells.
Endothelial diversity is an essential feature of the cardiovascular system, but its origin and mechanisms are incompletely understood. Whether endothelial diversity is an "intrinsic" property, independent of its location within the organ, cellular cross talk, and hemodynamic factors, is not yet clear. Recent studies have shown that endothelial diversity is not only reflected at the structural and functional level but also at the transcriptional level. Previous studies using microarray analysis, have shown that endothelial cells originating from distinct cardiovascular locations have unique expression patterns (8, 15, 16, 17). Based on the transcriptional profile of 53 endothelial cell cultures originating from different locations, Chi et al. (8) divided endothelial cells into several groups, according to their anatomical origin (large vessel vs. microvascular endothelium, arterial vs. venous endothelium, and microvascular endothelium from different tissues). Kallmann et al. (17) compared the expression profile of human cerebral endothelial cells and human umbilical cord vascular endothelial cells and identified 35 genes specific for brain endothelium, which included genes for the control of growth and neurotrophy, neuroprotection, angiogenesis, and immunoregulation.
In the heart, both the endocardial endothelium (EE) and cardiac microvascular endothelium (CMVE) share the property of close anatomical and functional interaction with cardiomyocytes (5). In the developing heart, the EE is responsible for myocardial trabeculation, cushion formation, and formation of Purkinje fibers (6, 13, 20). In the mature heart, EE and CMVE modulate cardiac muscle performance and growth (1, 6). Although EE and CMVE have similar functions in the adult heart, they have a different embryological origin. Furthermore, whereas the CMVE has a rather leaky structure (5, 7), EE cells show extensive intercellular overlap and a large number of gap junctions. This latter property suggests that the EE has a barrier function with properties comparable with the blood-brain barrier. Indeed, it has been shown that the EE influences the subendothelial myocardial ionic environment (11, 12).
In the present study, we studied the transcriptional profile of cardiac endothelial cells to test whether cardiac endothelial functional differentiation was reflected at the level of gene expression. We performed a single screening DNA microarray comparison between cultured EE and aortic endothelial (AE) cells. This experiment allowed us to identify a number of differentially expressed genes revealing that EE and AE cells express different genes when grown under identical culture conditions in the absence of the physiological differences present in vivo. These results further support a specific role for EE cells in the cardiovascular system and may provide novel underlying mechanistic insights.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Endocardial endothelium.
After dissection of the heart, the left and right ventricle were dissected, rinsed with PBS, and incubated in DMEM (Cambrex) containing 2 mg/ml collagenase and 0.5% streptomycin/penicillin solution for 20 min in a humidified incubator with 5% CO2 at 37°C. EE cells were gently scraped, rinsed with PBS, and collected by centrifugation at 1,600 rpm for 10 min. Cells were further processed as described above.
Cardiac microvascular endothelium.
After removal of the EE and removal of the epicardial coronaries, the left and right ventricles were cut into small pieces and incubated in 25 ml HBSS-Ca containing 0.08% (wt/vol) collagenase at 37°C for 30 min. After shearing by repeated pipetting, 25 ml trypsin solution (0.05%, wt/vol; Invitrogen) was added, and the fragments were incubated at 37°C for 30 min, then sheared by pipetting. The CMVE cells were subsequently collected by centrifugation at 700 rpm for 5 min and processed as described above.
Purity of the cell cultures was analyzed by staining with 15 µg Alexa Fluor 594 AcLDL (Molecular Probes) overnight at 37°C. This demonstrated a greater than 95% purity of AE, EE, and CMVE cells (Fig 1).
|
Affymetrix Microarray Analysis
Affymetrix oligonucleotide rat genome array GeneChips (RG-U34A) were used. This microarray GeneChip contains 8,800 transcripts, of which
5,350 represented known genes and 3,450 represented expressed sequences tags (ESTs) (
25% of the rat transcriptome, which contains
12,400 known genes and ESTs). Each gene or EST is represented on the GeneChip by 16 probe pairs. Each probe pair consists of a 25-bp oligonucleotide sequence that is a perfect match to the gene of interest and a 25-bp oligonucleotide containing a single base mismatch at bp 13. Affymetrix GeneChip analysis was performed according to recommended procedures. Briefly, total RNA was reverse-transcribed to double-stranded cDNA (Life Technologies), and biotinylated cRNA was generated by an in vitro transcription (Enzo). Labeled cRNA was purified (Qiagen), fragmented by alkaline treatment, and hybridized to a GeneChip array overnight at 45°C. The array was washed, stained with streptavidin phycoerythrin, and scanned. Each array was scanned twice, and an average intensity for each probe pair was generated. Data were analyzed using Affymetrix Microarray Suite (MAS 4.01) to assess quality of RNA and hybridization.
PCR and RT-PCR
PCR was performed with the ReadyMix RedTaq reaction mix (Sigma) in a reaction mixture containing 400 nM of both primers (Table 1) and 0.5 µl of template. After a 5-min denaturation at 92°C, 3035 cycles of PCR were performed consisting of a denaturation step at 92°C for 30 s, a primer annealing step at 55°C for 30 s, and a primer extension step at 72°C for 1 min, with a final extension step of 8 min.
|
Northern Blot Analysis
Probe construction and labeling.
Hybridization probes were generated by RT-PCR on RNA isolated from rat EE or AE. PCR fragments were analyzed by gel electrophoresis, excised from the gel, and purified using the QIAquick Gel Extraction Kit (Qiagen).
Approximately 25 ng of DNA probe was labeled in a 50-µl reaction volume containing 5 µl [
-32P]dCTP (3,000 Ci/mmol) using the Prime-It random primer labeling kit (Stratagene). Labeled probes were purified using the Chroma Spin+ TE-100 purification columns (Clontech).
RNA electrophoresis and Northern transfer.
Five micrograms of RNA was loaded on a 1.5% agarose gel containing 6.3% formaldehyde. Electrophoresis was performed in 1x MOPS buffer at a constant voltage of 120 V during 2 h. Following electrophoresis, RNA was transferred to a Nytran SuPerCharge nylon membrane (Schleicher and Schuell) with the TurboBlotter transfer system (Schleicher and Schuell). Subsequently, RNA was cross-linked with a CL-1000 ultraviolet cross-linker (UVP Inc.).
Hybridization.
Membranes were prehybridized in 10 ml of QuickHyb solution (Stratagene) for 30 min at 68°C. Hybridization was performed for 1 h at 68°C in QuickHyb solution containing the denatured labeled hybridization probe. Following hybridization, the membranes were washed at 50°C in wash buffers with increasing stringency, ranging from 2x SSC, 0.05% SDS to 0.1x SSC, 0.05% SDS, until background signals disappeared. Signals were visualized by autoradiography with Kodak Biomax MS film.
Real-Time Quantitative RT-PCR
Primers for real-time quantitative RT-PCR for all transcripts except macrophage metalloelastase (MME) (Table 2) were designed with the Primer Express software (Applied Biosystems). Reverse transcription was performed with the TaqMan reverse transcription reagents (Applied Biosystems) in a 50-µl reaction volume containing 5 µl total RNA solution (
1 µg), using 2.5 µM random hexamers. Samples were diluted to 250 µl, and 5 µl was used for real-time PCR in a 25-µl reaction volume containing 12.5 µl SYBR Green PCR Reaction Mix (Applied Biosystems) and 750 nM of both PCR primers. After an initial incubation for 2 min at 50°C and 10 min at 95°C, 45 PCR cycles were carried out consisting of a denaturation step of 15 s at 95°C and a primer annealing and elongation step of 1 min at 60°C, on an ABI Prism 7700 sequence detection system. Expression was normalized to GAPDH expression.
|
Immunofluorescent Staining
Cryosections were stained as published previously (11). In summary, following fixation with acetone for 10 min, cryosections were successively incubated with blocking solution [either goat or donkey IgG (Jackson ImmunoResearch), 0.2% BSA in PBS] for 30 min at room temperature, primary antibody (VWF, PECAM, DCN, ATPB1, GATA-GT2) for 24 h at 4°C, and secondary antibody [Alexa 488- or 594-labeled goat or donkey anti-IgG (Molecular Probes)] for 3 h at 37°C, and finally treated with SlowFade (Molecular Probes).
| RESULTS |
|---|
|
|
|---|
In subsequent validation experiments, about one-third of the genes with 10-fold or greater differential expression between EE and AE were chosen for validation by Northern blot analysis and/or real-time quantitative RT-PCR. For validation experiments, four additional and independent parallel cultures of AE and EE cells identical to those used for microarray analysis were analyzed. Figure 2 shows the results of Northern blot and real-time PCR (means + SE, n=4) of three genes preferentially expressed in AE, i.e., decorin (DCN, accession no. XM_216883), WDNM1 (accession no. X13309), and vasopressin receptor 1a (VPR1a, accession no. U39450) and three genes preferentially expressed in EE, i.e., sortilin (SORT, accession no. XM_215675), MME (accession no. X98517), and lysozyme (LYZ, accession no. L12459). Validations of other genes were performed with quantitative RT-PCR. Tables 3 and 4 show the results of the validation of 30 genes with pronounced preferential expression in EE (Table 3) and 10 genes with pronounced preferential expression in AE (Table 4), identified by the microarray analysis. Respectively, 24 and 6 of these genes indeed showed preferential expression in either cell type (Tables 3 and 4, Fig. 3).
|
|
|
|
In Vivo Validation
To test the validity of our findings in vivo, cryosections of rat heart and aorta were analyzed by immunofluorescent staining. Figure 4A shows double staining of aorta and heart with an antibody against DCN (red) and von Willebrand factor (VWF), an endothelium-specific marker (green). DCN, which was preferentially expressed in AE at the mRNA level in vitro, was abundantly expressed in AE in vivo but was absent in EE. Figure 4, B and C, respectively, show positive staining of heart and aorta for the ß1-subunit of the sodium-potassium ATPase (ATPB1, accession no. NM_013113) and GATA-GT2, two genes found to be preferentially expressed in EE at the mRNA level in vitro. Consistent with the mRNA data, both proteins were expressed in EE in vivo, but were absent in AE. These results demonstrate that the differential expression of mRNA between EE and AE in vitro reflects differences in vivo at the protein level.
|
|
|
| DISCUSSION |
|---|
|
|
|---|
EE cultures used for microarray analysis and validation experiments consisted of mixtures of EE cells isolated from left and right ventricles. Further analysis of 10 genes highly expressed in this left/right EE mixture, but nearly absent in AE, showed that the expression of these genes was similar in separate cultures of left and right ventricular EE, consistent with the concept that an intrinsic genetic "endocardial" program may exist in these endothelial cells. Interestingly, this "endocardial" program was only partly preserved in CMVE. Since CMVE is embryologically different from EE but shares an anatomical proximity and functional interaction with cardiomyocytes, this observation suggests that genes commonly expressed in EE and CMVE including GATA-GT2, oxidized low-density lipoprotein receptor 1 (OLR1), apolipoprotein E (APOE), creatine kinase brain type (CKB), parathyroid hormone receptor (PTHR), and UDP glucosyltransferase 1 (UGT1A7) participate in the functional interaction with cardiac myocytes.
Interpretation of the results at an individual gene level may provide novel mechanistic and functional insights into cardiac endothelial physiology. For example, three of the genes with preferential expression in EE encode for ion channels or ion channel related genes. These include an atypical voltage-gated Na+ channel (SCL11/SCN6a), ATPB1 (the ß1-subunit of the Na+-K+-ATPase), and GATA-GT2, which is the transcription factor for the H+-K+-ATPase (18). Previous observations from our laboratory suggest that the EE may act as an electrophysiological barrier that affects subendocardial ion concentrations (11, 12). In this process, a role for the Na+-K+-ATPase has already been implicated (11). The precise role of the ß1-subunit in the function of the Na+-K+-ATPase is not clear, but selective expression of one of the ß-subunit isoforms may reflect specific electrophysiological features of EE. Similarly, although the function of the atypical voltage-gated Na channel is not known, its expression in EE may unmask novel aspects of endothelial membrane ion transport. This also accounts for the H+-K+-ATPase, whose only known function is the control of gastric acid production. Preliminary studies in our laboratory, however, suggest that H+-K+-ATPase also plays a role in an endocardial transendothelial ion transport. H+-K+-ATPase activity may also be linked to the function of the sodium bicarbonate exchanger (NBC) (21), which was recently shown to be important for the regulation of subendocardial intracellular pH (12).
Another subset of genes differentially expressed between EE and AE relates to angiogenesis: macrophage metalloelastase (MME or MMP12) and decorin (DCN). This observation may indicate that both cell types have different angiogenetic properties. Gene activity of MME, the activator of angiostatin (9), was high in EE but very low in AE. mRNA for DCN, on the other hand, a gene expressed in sprouting endothelial cells and essential for angiogenesis (23), was nearly undetectable in EE but expressed at high levels in AE and CMVE. These results may suggest that the endocardial phenotype of the endothelial cell includes downscaled angiogenetic properties. Further experiments are required to test this hypothesis.
Finally, some of the genes preferentially expressed in EE are involved in embryonic cardiac development, cell growth, or proliferation. These include
-actinin-associated LIM protein (LIM), which plays an essential role in right ventricular development (19), transforming growth factor ß (TGF-ß) (22), and A5D3 protein (2). This observation is in agreement with the observation that the EE participates in growth responses of the embryonic as well as of the mature heart (6, 13, 20).
In conclusion, in the present study, we have shown molecular diversity of cardiac vs. aortic endothelial cells in vitro and in vivo. This diversity was preserved when the endothelial cells were removed from their specific biomechanical and biochemical environment. From these observations, we hypothesize the existence of an intrinsic genetic program for EE cells, microvascular cells, and AE cells. This program may be related to the modulatory role of the endocardium on cardiac development and function and may reveal specific functions of this endothelial phenotype.
| GRANTS |
|---|
|
|
|---|
| FOOTNOTES |
|---|
Address for reprint requests and other correspondence: G. W. De Keulenaer, Laboratory for Human Physiology and Pathophysiology, Dept. of Pharmacology, Univ. of Antwerp, Groenenborgerlaan 171, 2020 Antwerp, Belgium (E-mail: gilles.dekeulenaer{at}ua.ac.be).
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. J. Metcalf, T. D. Nightingale, H. L. Zenner, W. W. Lui-Roberts, and D. F. Cutler Formation and function of Weibel-Palade bodies J. Cell Sci., January 1, 2008; 121(1): 19 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Smith, D. Choi, T. J. Chipps, Y. Pan, D. O. Zamora, M. H. Davies, B. Babra, M. R. Powers, S. R. Planck, and J. T. Rosenbaum Unique Gene Expression Profiles of Donor-Matched Human Retinal and Choroidal Vascular Endothelial Cells Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2676 - 2684. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Jarvis and J. A. Nelson Human Cytomegalovirus Tropism for Endothelial Cells: Not All Endothelial Cells Are Created Equal J. Virol., March 1, 2007; 81(5): 2095 - 2101. [Full Text] [PDF] |
||||
![]() |
K. Lemmens, V. F. M. Segers, M. Demolder, and G. W. De Keulenaer Role of Neuregulin-1/ErbB2 Signaling in Endothelium-Cardiomyocyte Cross-talk J. Biol. Chem., July 14, 2006; 281(28): 19469 - 19477. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. F. M. Segers, I. Van Riet, L. J. Andries, K. Lemmens, M. J. Demolder, A. J. M. L. De Becker, M. M. Kockx, and G. W. De Keulenaer Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1370 - H1377. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |